Demonstration venue · read-only. Every page can be browsed; the buttons that would change it are switched off. Create an account to run TaxoReview on your own data. A simulation from public publication records: the people listed were not invited and did not agree to review.
? Tutorial for this page

Jesús López-Fidalgo

dblp:59/5212 · DBLP profile ↗
← Back
2ranked-venue papers
0as first author
1since 2021 · last 2025
0000-0001-7502-8188ORCID · verified

Domains — the database's venue-derived domains; a paper can count in several

Applied, interdisciplinary, general and emerging computing · 2 · 1 since 2021

Expertise — from the expertise taxonomy: the topics of the expert's papers under the CCF categories. A weight counts papers with recency: 1 for a paper about the topic, 0.3 when the topic is its context, halved every five years.

Interdisciplinary, comprehensive, and emerging computing
1 paper
Bioinformatics and computational biology · 100%

Topics — the 3 heaviest of 3, each with the papers that count most for it

TopicWeightPapersLastEvidence papers
Bioinformatics and computational biology › gene expression analysis
differential variability analysis
0.112006
Algorithm to find gene expression profiles of deregulation and identify families of disease-altered genes · Bioinform. 2006
Bioinformatics and computational biology › genomics › computational genomics
disease gene identification
0.112006
Algorithm to find gene expression profiles of deregulation and identify families of disease-altered genes · Bioinform. 2006
Bioinformatics and computational biology
gene expression analysis
0.112006
Algorithm to find gene expression profiles of deregulation and identify families of disease-altered genes · Bioinform. 2006
YearPublicationVenuePosition
2025 Optimal Subdata Selection for Prediction Based on the Distribution of the Covariates
abstract
Huge data sets are widely available now and there is growing interest in selecting an optimal subsample from the full data set to improve inference efficiency and reduce labeling costs. We propose a new criterion called J–optimality, that builds upon a popular optimal selection criterion that minimizes the Random–X prediction error by additionally incorporating the joint distribution of the covariates. A key advantage of our approach is that we can relate the subsampling selection problem to that of finding an optimal approximate design under a convex criterion, where analytical tools for finding and studying them are already available. Consequently, the J–optimal subsampling method comes with theoretical results and theory-based algorithms for finding them. Simulation results and real data analysis show our proposed methods outperform current subsampling methods and the proposed algorithms can also adapt efficiently to select an optimal subsample from streaming data.
Alvaro Cia-Mina, Jesús López-Fidalgo, Weng Kee Wong
IEEE Trans. Big Data2
2006 Algorithm to find gene expression profiles of deregulation and identify families of disease-altered genes
abstract
MOTIVATION: Alteration of gene expression often results in up- or down-regulated genes and the most common analysis strategies look for such differentially expressed genes. However, molecular disease mechanisms typically constitute abnormalities in the regulation of genes producing strong alterations in the expression levels. The search for such deregulation states in the genomic expression profiles will help to identify disease-altered genes better. RESULTS: We have developed an algorithm that searches for the genes which present a significant alteration in the variability of their expression profiles, by comparing an altered state with a control state. The algorithm provides groups of genes and assigns a statistical measure of significance to each group of genes selected. The method also includes a prefilter tool to select genes with a threshold of differential expression that can be set by the user ad casum. The method is evaluated using an experimental set of microarrays of human control and cancer samples from patients with acute promyelocytic leukemia.
Carlos Prieto, M. J. Rivas, J. M. Sánchez, Jesús López-Fidalgo, Javier De Las Rivas
Bioinform.4